Citizens Maintains Market Outperform on AtriCure, Lowers Price Target to $52
AtriCure, Inc. -0.10% Post
AtriCure, Inc. ATRC | 29.37 29.37 | -0.10% 0.00% Post |
Citizens analyst Daniel Stauder maintains AtriCure (NASDAQ:
ATRC) with a Market Outperform and lowers the price target from $60 to $52.
